4.5 Article

Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment

期刊

NEUROIMAGE-CLINICAL
卷 1, 期 1, 页码 179-187

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.nicl.2012.09.012

关键词

-

资金

  1. NIH [U01 AG024904, R01 EB008281, R01 AG020098, T32, P30 AG010129, K01 AG030514]
  2. NIH National Library of Medicine Training Grant [T15 LM07356]
  3. Alzheimer's Disease Neuroimaging Initiative (ADNI)
  4. Alzheimer's Disease Neuroimaging Initiative (NIH) [U01 AG024904]
  5. National Institute on Aging
  6. National Institute of Biomedical Imaging and Bioengineering
  7. Abbott
  8. AstraZeneca AB
  9. Bayer Schering Pharma AG
  10. Bristol-Myers Squibb
  11. Eisai Global Clinical Development
  12. Elan Corporation
  13. Genentech
  14. GE Healthcare
  15. GlaxoSmithKline
  16. Innogenetics
  17. Johnson and Johnson
  18. Eli Lilly and Co.
  19. Medpace, Inc.
  20. Merck and Co., Inc.
  21. Novartis AG
  22. Pfizer Inc
  23. F. Hoffman-La Roche
  24. Schering-Plough, Synarc, Inc.
  25. Wyeth
  26. Dana Foundation
  27. National Institute of Aging [AG20098, AG05133, AG15928]
  28. National Heart, Lung, and Blood Institute (NHLBI) [HL080295]
  29. National Institute on Aging (NIA) [AG15928, AG-023629, AG-20098, AG-027058]
  30. [HHSN268201200036C]
  31. [N01-HC-85239]
  32. [N01-HC-85079]
  33. [N01-HC-85086]
  34. [N01-HC-35129]
  35. [N01 HC-15103]
  36. [N01 HC-55222]
  37. [N01-HC-75150]
  38. [N01-HC-45133]
  39. DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC045133, N01HC015103] Funding Source: NIH RePORTER
  40. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL080295] Funding Source: NIH RePORTER
  41. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008281] Funding Source: NIH RePORTER
  42. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER
  43. NATIONAL INSTITUTE ON AGING [R01AG027058, P30AG010129, K01AG030514, U01AG024904, R01AG015928, R01AG023629, R01AG020098, R56AG020098, R56AG023629, P50AG005133] Funding Source: NIH RePORTER
  44. NATIONAL LIBRARY OF MEDICINE [T15LM007356] Funding Source: NIH RePORTER

向作者/读者索取更多资源

A commonly carried C677T polymorphism in a folate-related gene, MTHFR, is associated with higher plasma homocysteine, a well-known mediator of neuronal damage and brain atrophy. As homocysteine promotes brain atrophy, we set out to discover whether people carrying the C677T MTHFR polymorphism which increases homocysteine, might also show systematic differences in brain structure. Using tensor-based morphometry, we tested this association in 359 elderly Caucasian subjects with mild cognitive impairment (MCI) (mean age: 75 +/- 7.1 years) scanned with brain MRI and genotyped as part of Alzheimer's Disease Neuroimaging Initiative. We carried out a replication study in an independent, non-overlapping sample of 51 elderly Caucasian subjects with MCI (mean age: 76 +/- 5.5 years), scanned with brain MRI and genotyped for MTHFR, as part of the Cardiovascular Health Study. At each voxel in the brain, we tested to see where regional volume differences were associated with carrying one or more MTHFR 'T' alleles. In ADNI subjects, carriers of the MTHFR risk allele had detectable brain volume deficits, in the white matter, of up to 2-8% per risk T allele locally at baseline and showed accelerated brain atrophy of 0.5-1.5% per T allele at 1 year follow-up, after adjusting for age and sex. We replicated these brain volume deficits of up to 5-12% per MTHFR T allele in the independent cohort of CHS subjects. As expected, the associations weakened after controlling for homocysteine levels, which the risk gene affects. The MTHFR risk variant may thus promote brain atrophy by elevating homocysteine levels. This study aims to investigate the spatially detailed effects of this MTHFR polymorphism on brain structure in 3D, pointing to a causal pathway that may promote homocysteine-mediated brain atrophy in elderly people with MCI. (C) 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging

Janina Krell-Roesch, Martin Rakusa, Jeremy A. Syrjanen, Argonde C. van Harten, Val J. Lowe, Clifford R. Jack, Walter K. Kremers, David S. Knopman, Gorazd B. Stokin, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda

Summary: This study examined the association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms in older non-demented adults. The results showed that lower CSF Aβ42 and higher t-tau/Aβ42 and p-tau/Aβ42 ratios were associated with depression, anxiety, and other NPS.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Biomarker clustering in autosomal dominant Alzheimer's disease

Patrick H. Luckett, Charlie Chen, Brian A. Gordon, Julie Wisch, Sarah B. Berman, Jasmeer P. Chhatwal, Carlos Cruchaga, Anne M. Fagan, Martin R. Farlow, Nick C. Fox, Mathias Jucker, Johannes Levin, Colin L. Masters, Hiroshi Mori, James M. Noble, Stephen Salloway, Peter R. Schofield, Adam M. Brickman, William S. Brooks, David M. Cash, Michael J. Fulham, Bernardino Ghetti, Clifford R. Jack, Jonathan Voeglein, William E. Klunk, Robert Koeppe, Yi Su, Michael Weiner, Qing Wang, Daniel Marcus, Deborah Koudelis, Nelly Joseph-Mathurin, Lisa Cash, Russ Hornbeck, Chengjie Xiong, Richard J. Perrin, Celeste M. Karch, Jason Hassenstab, Eric McDade, John C. Morris, Tammie L. S. Benzinger, Randall J. Bateman, Beau M. Ances

Summary: This study analyzed 19 biomarkers of Alzheimer's disease using hierarchical clustering and feature selection, and found that amyloid and tau measures were the primary predictors. Emerging biomarkers of neuronal integrity and inflammation showed weaker predictive ability.

ALZHEIMERS & DEMENTIA (2023)

Article Geriatrics & Gerontology

Association of Indication for Hospitalization with Subsequent Amyloid PET and MRI Biomarkers

Juraj Sprung, Mariana L. Laporta, David S. Knopman, Ronald C. Petersen, Michelle M. Mielke, Clifford R. Jack, David P. Martin, Andrew C. Hanson, Darrell R. Schroeder, Phillip J. Schulte, Scott A. Przybelski, Diana J. Valencia Morales, Toby N. Weingarten, Prashanthi Vemuri, David O. Warner

Summary: This study found that hospitalization in older adults is associated with accelerated cortical thinning, amyloid accumulation, and white matter hyperintensities (WMH) increases, especially in medical hospitalizations. However, these changes were modest and did not translate to an increased risk of crossing the abnormality threshold.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Physical Frailty and Brain White Matter Abnormalities: The Atherosclerosis Risk in Communities Study

Emma L. Ducca, Gabriela T. Gomez, Priya Palta, Kevin J. Sullivan, Clifford R. Jack, David S. Knopman, Rebecca F. Gottesman, Jeremy Walston, B. Gwen Windham, Keenan A. Walker

Summary: The study found a strong association between cerebral white matter structure and current and future frailty. Specifically, white matter hyperintensity volume was significantly associated with frailty. However, measures of white matter microstructure were not generally associated with progression from nonfrail to frail status.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Relationships of Cerebral Perfusion With Gait Speed Across Systolic Blood Pressure Levels and Age: A Cohort Study

B. Gwen Windham, Michael E. Griswold, Radhikesh Ranadive, Kevin Sullivan, Thomas H. Mosley, Michelle M. Mielke, Clifford R. Jack, Dave Knopman, Ron Petersen, Prashanthi Vemuri

Summary: This study aimed to examine if the association between cerebral perfusion and gait speed is influenced by systolic blood pressure and age. The results showed that poorer cerebral perfusion is associated with slower gait speeds, particularly with older age, while higher perfusion can significantly attenuate age-related differences in gait speed.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Computer Science, Artificial Intelligence

Signed graph representation learning for functional-to-structural brain network mapping

Haoteng Tang, Lei Guo, Xiyao Fu, Yalin Wang, Scott Mackin, Olusola Ajilore, Alex D. Leow, Paul M. Thompson, Heng Huang, Liang Zhan

Summary: MRI-derived brain networks are widely used to understand interactions among brain regions and their relationships with brain development and diseases. Graph mining on these networks can help discover biomarkers for clinical phenotypes and neurodegenerative diseases. Most current studies focus on projecting structural networks onto functional networks to extract a fused representation.

MEDICAL IMAGE ANALYSIS (2023)

Article Multidisciplinary Sciences

Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment

Chenzhong Yin, Phoebe Imms, Mingxi Cheng, Anar Amgalan, Nahian F. Chowdhury, Roy J. Massett, Nikhil N. Chaudhari, Xinghe Chen, Paul M. Thompson, Paul Bogdan, Andrei Irimia

Summary: This study introduces a convolutional neural network (CNN) to estimate brain age (BA) from magnetic resonance images (MRIs) and achieves lower estimation errors compared to previous studies. The CNN provides detailed brain aging maps that reveal sex differences and neurocognitive trajectories in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD). BA is shown to capture dementia symptom severity, functional disability, and executive function better than chronological age (CA) in individuals with MCI. The proposed framework can systematically map the relationship between aging-related neuroanatomy changes and neurocognitive measures in both cognitively normal individuals and those with MCI or AD, aiding in early identification of AD risk.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Clinical Neurology

Changes in Cardiovascular Health Across Midlife and Late-Life and Magnetic Resonance Imaging Markers of Cerebral Vascular Disease in Late-Life

Sanaz Sedaghat, Yuekai Ji, Jean-Philippe Empana, Timothy M. Hughes, Thomas H. Mosley, Rebecca F. Gottesman, Michael Griswold, Clifford R. Jack, Pamela L. Lutsey, Thomas T. van Sloten

Summary: This study aimed to investigate the association of cardiovascular health in midlife and late-life as well as changes in cardiovascular health between these periods with the prevalence of cerebral vascular disease in late-life. The results showed that better cardiovascular health in midlife, improvement of cardiovascular health within midlife, higher cardiovascular health at late-life, and improvement of cardiovascular health from midlife to late-life were associated with a lower prevalence of cerebral vascular disease markers in late-life. Therefore, improving cardiovascular health in midlife and late-life may help prevent the development of cerebral vascular disease.

STROKE (2023)

Article Oncology

Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls †

Kelly Nudelman, Kwangsik Nho, Michael Zhang, Brenna C. McDonald, Wanting Zhai, Brent J. Small, Claire E. Wegel, Paul B. Jacobsen, Heather S. L. Jim, Sunita K. Patel, Deena M. A. Graham, Tim A. Ahles, James C. Root, Tatiana Foroud, Elizabeth C. Breen, Judith E. Carroll, Jeanne S. Mandelblatt, Andrew J. Saykin

Summary: This study found that genetics may play an important role in modifying risk for cognitive decline in older female breast cancer survivors. Several genetic variants and genes were identified to be associated with differences in patterns of cognitive decline in cancer patients compared to controls. Further research and validation of these findings in other cancer populations is necessary to inform therapeutic research and evaluations of risk for cognitive decline in older cancer survivors.

CANCERS (2023)

Article Health Care Sciences & Services

An Emerging Screening Method for Interrogating Human Brain Function: Tutorial

Gustavo Sudre, Anto Bagic, James T. Becker, John P. Ford

Summary: In this study, using neuroimaging data and a whole-head Elekta Neuromag 306 sensor system, a set of features strongly correlated with brain function were derived. These features can serve as a noninvasive quantitative tool for clinicians to screen and monitor cognitive function in at-risk individuals. The set of features were able to effectively differentiate between participants with normative and nonnormative brain function, and accurately predict participants' Mini-Mental Test score.

JMIR FORMATIVE RESEARCH (2023)

Article Clinical Neurology

Association of Olfaction and Microstructural Integrity of Brain Tissue in Community-Dwelling Adults

Srishti Shrestha, Xiaoqian Zhu, Kevin J. Sullivan, Chad Blackshear, Jennifer A. Deal, A. Richey Sharrett, Vidyulata Kamath, Andrea L. C. Schneider, Clifford R. Jack, Juebin Huang, Priya Palta, Robert I. Reid, David S. Knopman, Rebecca F. Gottesman, Honglei Chen, B. Gwen Windham, Michael E. Griswold, Jr Thomas H. Mosley

Summary: Research shows that neuronal microstructural integrity in multiple brain regions, particularly the medial temporal lobe (MTL), is associated with odor identification ability. The associations between microstructural integrity and olfaction are stronger in individuals with mild cognitive impairment (MCI) compared to those with normal cognition, suggesting different effects of dementia pathogenesis.

NEUROLOGY (2023)

Article Clinical Neurology

Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume The ARIC Study

Keenan A. Walker, Ron C. Hoogeveen, Aaron R. Folsom, Christie M. Ballantyne, David S. Knopman, B. Gwen Windham, Clifford R. Jack Jr, Rebecca F. Gottesman

Summary: In the article "Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume: The ARIC Study" by Walker et al., coding errors were found to have affected the statistical analyses. The authors have corrected the errors and reanalyzed the data, stating that the errors did not change the overall message of the article. The identified errors include misclassification of a nominal covariate, use of incorrect alcohol use covariate, and an error in the scaling of beta coefficients.

NEUROLOGY (2023)

Article Clinical Neurology

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Rioghna R. Pittock, Jeremiah A. Aakre, Anna M. Castillo, Vijay K. Ramanan, Walter K. Kremers, Clifford R. Jack Jr, Prashanthi Vemuri, Val J. Lowe, David S. Knopman, Ronald C. Petersen, Jonathan Graff-Radford, Maria Vassilaki

Summary: Treatment options for Alzheimer's disease are limited, and research on the applicability of anti-beta-amyloid monoclonal antibodies in the general population is lacking. This study aims to assess the generalizability of anti-amyloid treatment and apply the eligibility criteria of two clinical trials to a population-based sample.

NEUROLOGY (2023)

Article Cell Biology

A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease

Rafi Haque, Caroline M. Watson, Jiaqi Liu, E. Kathleen Carter, Duc M. Duong, James J. Lah, Aliza P. Wingo, Blaine R. Roberts, Erik C. B. Johnson, Andrew J. Saykin, Leslie M. Shaw, Nicholas T. Seyfried, Thomas S. Wingo, Allan I. Levey

Summary: This study developed a reliable and high-throughput mass spectrometry assay to detect 48 key proteins in cerebrospinal fluid (CSF), and found that this panel of proteins performed at least as well as existing biomarkers in predicting clinical diagnosis, brain imaging results, cognitive decline, and dementia severity in Alzheimer's disease. Combining this panel with existing biomarkers significantly improved diagnostic accuracy and prediction of disease progression.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Genetics & Heredity

Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: Main Effects and Disease Stage-Specific Interactions

Thea J. Rosewood, Kwangsik Nho, Shannon L. Risacher, Sujuan Gao, Li Shen, Tatiana Foroud, Andrew J. Saykin

Summary: The genetic susceptibility for Alzheimer's disease (AD) is not fully understood. This study used an endophenotype approach to identify genetic associations and discovered novel genetic loci related to AD. These findings provide deeper insights into the genetic mechanisms underlying AD.
暂无数据